Kuang Jing, Zhao Mei, Li Huilian, Dang Wei, Li Wei
Department of Plastic Surgery, Jinan Central Hospital Affiliated to Shandong University, Jinan, Shandong 250013, P.R. China.
Department of News Office, Jinan Central Hospital Affiliated to Shandong University, Jinan, Shandong 250013, P.R. China.
Oncol Lett. 2016 May;11(5):3009-3014. doi: 10.3892/ol.2016.4358. Epub 2016 Mar 21.
The present study aimed to identify the potential target genes and underlying molecular mechanisms involved in head and neck squamous cell carcinoma (HNSCC) by bioinformatics analysis. Microarray data of a Gene Expression Omnibus series GSE6631 was downloaded from the Gene Expression Omnibus database, which was generated from paired samples of HNSCC and normal tissue from 22 patients, and was used to identify differentially expressed genes (DEGs). Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes enrichment analyses were performed to investigate the functions of the identified DEGs. Furthermore, the protein-protein interaction (PPI) network of these DEGs was constructed using Cytoscape software. Between HNSCC and normal samples there was a difference in 419 DEGs, including 196 upregulated and 223 downregulated genes. The upregulated DEGs were mainly enriched in GO terms of cell adhesion, extracellular matrix (ECM) organization and collagen metabolic process, while the downregulated DEGs were mainly associated with epidermis development and epidermal cell differentiation. The DEGs were enriched in pathways such as ECM-receptor interaction, focal adhesion and drug metabolism. Fibronectin 1 (FN1), epidermal growth factor receptor (EGFR), collagen type I alpha 1 (COL1A1) and matrix metallopeptidase-9 (MMP-9) were hub nodes in the PPI network. These results suggested that cell adhesion and drug metabolism may be associated with HNSCC development, and genes such as FN1, EGFR, COL4A1 and MMP-9 may be potential therapeutic target genes in HNSCC.
本研究旨在通过生物信息学分析确定头颈部鳞状细胞癌(HNSCC)中潜在的靶基因及潜在分子机制。从基因表达综合数据库下载了基因表达综合系列GSE6631的微阵列数据,该数据由22例患者的HNSCC与正常组织配对样本生成,用于鉴定差异表达基因(DEG)。进行基因本体(GO)和京都基因与基因组百科全书富集分析以研究鉴定出的DEG的功能。此外,使用Cytoscape软件构建这些DEG的蛋白质-蛋白质相互作用(PPI)网络。在HNSCC与正常样本之间,有419个DEG存在差异,包括196个上调基因和223个下调基因。上调的DEG主要富集于细胞黏附、细胞外基质(ECM)组织和胶原代谢过程的GO术语,而下调的DEG主要与表皮发育和表皮细胞分化相关。这些DEG富集于ECM-受体相互作用、黏着斑和药物代谢等途径。纤连蛋白1(FN1)、表皮生长因子受体(EGFR)、I型胶原α1(COL1A1)和基质金属蛋白酶-9(MMP-9)是PPI网络中的枢纽节点。这些结果表明,细胞黏附和药物代谢可能与HNSCC的发生发展相关,而FN1、EGFR、COL4A1和MMP-9等基因可能是HNSCC潜在的治疗靶基因。